Vemurafenib for BRAF(V600E)-positive metastatic papillary thyroid cancer - Authors' response.
Lancet Oncol. 2016 Nov;17(11):e469
Authors: Brose MS, Singh N
PMID: 27819236 [PubMed - in process]
http://ift.tt/2ehMjN5
Vemurafenib for BRAF(V600E)-positive metastatic papillary thyroid cancer - Authors' response.
Lancet Oncol. 2016 Nov;17(11):e469
Authors: Brose MS, Singh N
PMID: 27819236 [PubMed - in process]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου